Mazaheri R, Rode H N, Abikar K, Ing A, Nohr C, Gordon J
J Clin Immunol. 1984 Jan;4(1):65-70. doi: 10.1007/BF00915289.
The experiments described have shown that, whereas the injection of tetanus toxoid (tet) into 8 of 12 control individuals resulted in the appearance of specific anti-tet-IgG antibodies in their plasma, immunization of 14 anergic patients did not elicit an antibody response. This observation was extended to an in vitro system, where cells from four control subjects were shown to secrete anti-tet-IgG antibodies in response to polyclonal activators whereas cells from eight anergic patients did not. It is suggested that this failure of humoral immunity could account for the high risk of bacterial infections in anergy.
上述实验表明,向12名对照个体中的8名注射破伤风类毒素(tet)后,其血浆中出现了特异性抗tet-IgG抗体,而对14名无反应性患者进行免疫并未引发抗体反应。这一观察结果扩展到了体外系统,在该系统中,来自4名对照受试者的细胞在受到多克隆激活剂刺激后会分泌抗tet-IgG抗体,而来自8名无反应性患者的细胞则不会。有人认为,体液免疫的这种缺陷可能是导致无反应性个体发生细菌感染风险高的原因。